Vanda Pharmaceuticals Inc (VNDA)
5.10
-0.36
(-6.59%)
USD |
NASDAQ |
Nov 14, 16:00
5.10
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Free Cash Flow (Quarterly): -14.74M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -14.74M |
| June 30, 2024 | -7.036M |
| March 31, 2024 | 7.562M |
| December 31, 2023 | -3.985M |
| September 30, 2023 | -2.074M |
| June 30, 2023 | -13.28M |
| March 31, 2023 | 31.75M |
| December 31, 2022 | 9.153M |
| September 30, 2022 | 12.69M |
| June 30, 2022 | 5.492M |
| March 31, 2022 | 3.971M |
| December 31, 2021 | 26.47M |
| September 30, 2021 | 9.407M |
| June 30, 2021 | 18.72M |
| March 31, 2021 | 9.063M |
| December 31, 2020 | 18.34M |
| September 30, 2020 | 9.128M |
| June 30, 2020 | 23.80M |
| March 31, 2020 | -1.28M |
| December 31, 2019 | 9.723M |
| September 30, 2019 | 5.704M |
| June 30, 2019 | 20.25M |
| March 31, 2019 | 9.25M |
| December 31, 2018 | 15.24M |
| September 30, 2018 | 8.558M |
| Date | Value |
|---|---|
| June 30, 2018 | -20.68M |
| March 31, 2018 | 1.503M |
| December 31, 2017 | 3.275M |
| September 30, 2017 | 1.797M |
| June 30, 2017 | -2.884M |
| March 31, 2017 | -5.835M |
| December 31, 2016 | -1.88M |
| September 30, 2016 | 0.642M |
| June 30, 2016 | -3.373M |
| March 31, 2016 | -4.899M |
| December 31, 2015 | -1.07M |
| September 30, 2015 | -5.725M |
| June 30, 2015 | 11.94M |
| March 31, 2015 | 4.772M |
| December 31, 2014 | -13.72M |
| September 30, 2014 | -7.652M |
| June 30, 2014 | -36.91M |
| March 31, 2014 | -32.04M |
| December 31, 2013 | -12.25M |
| September 30, 2013 | -10.28M |
| June 30, 2013 | -8.092M |
| March 31, 2013 | -9.148M |
| December 31, 2012 | -13.86M |
| September 30, 2012 | -10.18M |
| June 30, 2012 | -12.36M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-14.74M
Minimum
Sep 2024
31.75M
Maximum
Mar 2023
7.644M
Average
9.096M
Median
Free Cash Flow (Quarterly) Benchmarks
| Zevra Therapeutics Inc | -19.11M |
| Black Diamond Therapeutics Inc | -11.32M |
| Edgewise Therapeutics Inc | -27.89M |
| NovaBay Pharmaceuticals Inc | -2.063M |
| Palatin Technologies Inc | -6.477M |